Cytoplasmic oestrogen receptor replenishment: oestrogens versus anti-oestrogens

Area of Science:

• Endocrinology
• Molecular Biology
• Reproductive Science

Background:

• The uterotrophic process is a key indicator of oestrogen activity.
• Understanding oestrogen receptor dynamics is crucial for reproductive health research.

Purpose of the Study:

• To investigate the effects of various triphenylethylene antioestrogens and different doses of estradiol-17 beta (Oe2) on uterine growth.
• To analyze the impact on uterine oestrogen receptor nuclear accumulation, cytoplasmic depletion, and replenishment.

Main Methods:

• In vivo administration of antioestrogens and Oe2 to determine uterotrophic effects.
• Measurement of uterine wet weight, total protein, and incorporation of [3H]thymidine and [14C]leucine.
• Quantification of cytoplasmic oestrogen receptor levels at 24 and 48 hours post-injection.

Main Results:

• Estradiol-17 beta (Oe2), regardless of dose, induced similar changes in uterine wet weight, protein, and DNA/protein synthesis at 24 hours.
• The net increase in cytoplasmic oestrogen receptor after Oe2 injection was dose-independent.
• Antioestrogens demonstrated a similar effect on cytoplasmic oestrogen receptor increase as Oe2, suggesting newly synthesized receptor.

Conclusions:

• Both physiological and pharmacological doses of Oe2 elicit comparable uterotrophic responses.
• Antioestrogens mimic Oe2's effect on cytoplasmic oestrogen receptor levels.
• The findings suggest that Oe2 induces receptor replenishment, potentially through a recycling mechanism, and antioestrogens stimulate new receptor synthesis.